找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Intellectual Property Rights in Pharmaceutical Test Data; Origins, Globalisati Adam Buick Book 2023 The Editor(s) (if applicable) and The A

[復(fù)制鏈接]
樓主: 小費(fèi)
11#
發(fā)表于 2025-3-23 13:25:21 | 只看該作者
Approaches to the Implementation of the Protection of Submitted Test Data, first considers how submitted test data is protected in jurisdictions which do not provide test data exclusivity rights, before moving to consider differing approaches to test data exclusivity itself through an analysis of the test data exclusivity provisions of 27 jurisdictions..The analysis in th
12#
發(fā)表于 2025-3-23 17:17:50 | 只看該作者
The Impact of Test Data Exclusivity on Abbreviated New Drug Applications in the United States,eference new chemical entities which qualified for test data exclusivity in the US between 1999 and 2009. The findings of this analysis show that test data exclusivity would appear to have an impact on the date of first generic approval for about 8% of new chemical entities approved in the US in the
13#
發(fā)表于 2025-3-23 21:33:58 | 只看該作者
The Impact of Test Data Exclusivity on Measures for the Protection of Public Health,gins by examining the general relationship between test data exclusivity and the use of compulsory licensing since the signing of the TRIPS Agreement, before turning to consider the role of test data exclusivity in the context of the response to the COVID-19 pandemic specifically..The analysis of th
14#
發(fā)表于 2025-3-24 00:23:54 | 只看該作者
15#
發(fā)表于 2025-3-24 05:57:51 | 只看該作者
Adam Buickten (insbes. Art. 2 II S. 1 GG) und dem Anliegen der Wissenschaftsfreiheit (Art. 5 III GG) inh?rent, letzteres doppelfunktional sowohl auf das Gemeinwohlinteresse als auch auf das Recht jedes einzelnen Forschers bezogen. Das Recht ist dementsprechend vor die Herausforderung gestellt, beide wertbezog
16#
發(fā)表于 2025-3-24 09:58:07 | 只看該作者
17#
發(fā)表于 2025-3-24 14:44:55 | 只看該作者
Adam Buick4. Half of their members (including the chairperson) are required to be laypeople, and the committees are not associated with the institutions in which research is conducted. There are some other research ethics committees, but these committees also have a large lay element and independent chairpers
18#
發(fā)表于 2025-3-24 15:41:51 | 只看該作者
19#
發(fā)表于 2025-3-24 21:44:47 | 只看該作者
Adam Buickegularien auf das deutsche Arzneimittelrecht zu beobachten. Die Deklaration von Helsinki als (rechtlich unverbindliches) medizinethisches Dokument enth?lt in ihrer aktuellsten Fassung von Seoul die bemerkenswerte Grundwertung, dass dem Wohlbefinden der einzelnen Patienten stets vorrangiges Gewicht z
20#
發(fā)表于 2025-3-25 02:45:04 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-4 22:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
鄂托克前旗| 利辛县| 日土县| 吴堡县| 阿图什市| 广南县| 和硕县| 通许县| 时尚| 兴安县| 翁牛特旗| 鄂尔多斯市| 武川县| 三门峡市| 乌拉特中旗| 临潭县| 武义县| 湘潭县| 竹山县| 刚察县| 冀州市| 忻州市| 资溪县| 宾阳县| 普兰县| 大理市| 泾川县| 萝北县| 邵武市| 孝感市| 乐昌市| 错那县| 铁岭市| 兴化市| 宜昌市| 湖州市| 喜德县| 上林县| 昌乐县| 南乐县| 延津县|